Response to Imatinib in a Patient With Gastric Adenocarcinoma With KIT Q556_K558 In-Frame Deletion: A Case Report.

Authors :: Ninomiya, Kiichiro
Ennishi, Daisuke
Okamoto, Kunio
Ando, Midori
Nakamura, Satoko
Tomida, Shuta
Ayada, Yoshiyuki
Makimoto, Go
Ichihara, Eiki
Okita, Natsuko
Toyooka, Shinichi
Maeda, Yoshinobu
Tabata, Masahiro
Source :: JCO Precision Oncology. 9/19/2024, Vol. 8, p1-5. 5p.
Publication Year :: 2024
Abstract: Imatinib may be a useful targeted agent for patients with advanced gastric adenocarcinoma who have KIT mutations. [ABSTRACT FROM AUTHOR]

Full Text Access

Tools